Literature DB >> 11949947

Macrophages, oxidation, and endometriosis.

Nalini Santanam1, Ana A Murphy, Sampath Parthasarathy.   

Abstract

Retrograde menstruation has been suggested to be the cause for the presence of endometrial cells in the peritoneal cavity. However, little is known about the events that lead to the adhesion and growth of these cells that ultimately result in endometriosis, considering the fact that the disease occurs only in certain women despite the common occurrence of retrograde menstruation in most women. We postulate that, in normal women, the endometrial cells and tissue that arrive in the peritoneal cavity during menstruation are effectively removed by macrophages that are chemoattracted and become resident tissue macrophages in the peritoneal cavity. In contrast, the peritoneal macrophages in women with endometriosis are nonadherent and ineffectively scavenged, resulting in the sustained presence and growth of the endometrial cells. We also postulate that the peritoneal fluid is not a passive reservoir of the factors secreted by cells of the peritoneum, but actively promotes endometriosis. The peritoneal fluid is rich in lipoproteins, particularly low-density lipoprotein, which generates oxidized lipid components in a macrophage-rich inflammatory milieu. The oxidants exacerbate the growth of endometriosis by inducing chemoattractants such as MCP-1 and endometrial cell growth-promoting activity. We provide evidence for the presence of oxidative milieu in the peritoneal cavity of women with endometriosis, the nonscavenging properties of macrophages that are nonadherent, and the synergistic interaction between macrophages, oxidative stress, and the endometrial cells. For example, the peritoneal fluid lipoproteins of subjects with endometriosis have increased the propensity to undergo oxidation as compared with plasma lipoproteins, and the subjects also have increased titer of autoantibodies to oxidatively modified proteins. If the oxidative proinflammatory nature of the peritoneal fluid is an important mediator of endometriosis growth, anti-inflammatory agents and antioxidants might afford protection against endometriosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11949947     DOI: 10.1111/j.1749-6632.2002.tb02779.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  26 in total

1.  Antioxidant supplementation reduces endometriosis-related pelvic pain in humans.

Authors:  Nalini Santanam; Nino Kavtaradze; Ana Murphy; Celia Dominguez; Sampath Parthasarathy
Journal:  Transl Res       Date:  2012-05-31       Impact factor: 7.012

Review 2.  Novel therapies targeting endometriosis.

Authors:  Hugh S Taylor; Kevin G Osteen; Kaylon L Bruner-Tran; Charles J Lockwood; Graciela Krikun; Anna Sokalska; Antoni J Duleba
Journal:  Reprod Sci       Date:  2011-06-21       Impact factor: 3.060

Review 3.  Pathogenesis of Endometriosis: Roles of Retinoids and Inflammatory Pathways.

Authors:  Robert N Taylor; Maureen A Kane; Neil Sidell
Journal:  Semin Reprod Med       Date:  2015-07-01       Impact factor: 1.303

4.  Current assessment of the (dys)function of macrophages in endometriosis and its associated pain.

Authors:  Sarah Brunty; Nalini Santanam
Journal:  Ann Transl Med       Date:  2019-12

5.  Simvastatin induces apoptosis and alters cytoskeleton in endometrial stromal cells.

Authors:  Anna Sokalska; Donna H Wong; Amanda Cress; Piotr C Piotrowski; Izabela Rzepczynska; Jesus Villanueva; Antoni J Duleba
Journal:  J Clin Endocrinol Metab       Date:  2010-04-28       Impact factor: 5.958

6.  Association Between Endometriosis and Hypercholesterolemia or Hypertension.

Authors:  Fan Mu; Janet Rich-Edwards; Eric B Rimm; Donna Spiegelman; John P Forman; Stacey A Missmer
Journal:  Hypertension       Date:  2017-05-30       Impact factor: 10.190

7.  Resveratrol inhibits development of experimental endometriosis in vivo and reduces endometrial stromal cell invasiveness in vitro.

Authors:  Kaylon L Bruner-Tran; Kevin G Osteen; Hugh S Taylor; Anna Sokalska; Kaitlin Haines; Antoni J Duleba
Journal:  Biol Reprod       Date:  2010-09-15       Impact factor: 4.285

8.  Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.

Authors:  Jesus A Villanueva; Anna Sokalska; Amanda B Cress; Israel Ortega; Kaylon L Bruner-Tran; Kevin G Osteen; Antoni J Duleba
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

9.  Myeloperoxidase as a Potential Target in Women With Endometriosis Undergoing IVF.

Authors:  Nalini Santanam; Nathaniel Zoneraich; Sampath Parthasarathy
Journal:  Reprod Sci       Date:  2016-09-27       Impact factor: 3.060

10.  Simvastatin protects against the development of endometriosis in a nude mouse model.

Authors:  Kaylon L Bruner-Tran; Kevin G Osteen; Antoni J Duleba
Journal:  J Clin Endocrinol Metab       Date:  2009-04-14       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.